SCHEMBL6165558

SCHEMBL6165558

CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC(O)C1

nearest known ligand 0.76

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.66
MAPK1 P28482 1/20 0.62
PABPC1 P11940 1/20 0.58
HRH2 P25021 1/20 0.56
HRH1 P35367 1/20 0.56
ACE P12821 2/20 0.54
CTSS P25774 2/20 0.53
CTSL P07711 1/20 0.53
CTSB P07858 1/20 0.53
CTSK P43235 1/20 0.53
ADORA1 P30542 1/20 0.51
CYP51A1 Q16850 1/20 0.50
SCN9A Q15858 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
AKT1 P31749 1/20 0.49
ATM Q13315 1/20 0.49
F2 P00734 1/20 0.48
PRSS1 P07477 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6165550 1.00 KMT2A (0.66) KMT2AMAPK1PABPC1HRH2HRH1
SCHEMBL6165554 1.00 KMT2A (0.66) KMT2AMAPK1PABPC1HRH2HRH1
SCHEMBL6162484 0.94 KMT2A (0.71) KMT2AMAPK1PABPC1HRH2HRH1
SCHEMBL6162477 0.94 KMT2A (0.71) KMT2AMAPK1PABPC1HRH2HRH1
SCHEMBL6162815 0.94 KMT2A (0.71) KMT2AMAPK1PABPC1HRH2HRH1
SCHEMBL6162796 0.91 KMT2A (0.62) KMT2AMAPK1PABPC1HRH2HRH1
SCHEMBL28760270 0.90 PABPC1 (0.59) KMT2AMAPK1PABPC1HRH2HRH1
SCHEMBL2106972 0.90 PABPC1 (0.59) KMT2AMAPK1PABPC1HRH2HRH1
SCHEMBL2106973 0.90 PABPC1 (0.59) KMT2AMAPK1PABPC1HRH2HRH1
SCHEMBL31278578 0.89 ALDH1A1 (0.58) KMT2AMAPK1PABPC1HRH2HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-0832065-B1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER (US) 2001-10-10 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-6277877-B1 GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS PFIZER, INC. 2001-08-21 US disclosed
US-6107329-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS PFIZER, INC. (US) 2000-08-22 US disclosed
EP-0832065-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER INC. (US) 1998-04-01 EP disclosed
CN-1142492-A Substituted N-(indole-2-carbonyl)-glycinamides and derivatives as antidiabetic agents PFIZER (US) 1997-02-12 CN disclosed
WO-1996039384-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER, INC. (US) 1996-12-12 WO disclosed